Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.

Frederique Ponchel Laurence DuquenneXuanxiao XieDiane CorscaddenFarag ShuweihdiKulveer MankiaL A TrouwPaul Emery

Published in: RMD open (2022)

We confirm added value of multiple AutoAbs testing for identifying progressors to clinical disease, allowing more specific stratification for intervention studies.

Keyphrases

randomized controlled trial
rheumatoid arthritis
oxidative stress